215 related articles for article (PubMed ID: 25345982)
1. Targeting of rifamycin SV to the colon for treatment of travelers' diarrhea: a randomized, double-blind, placebo-controlled phase 3 study.
DuPont HL; Petersen A; Zhao J; Mundt A; Jiang ZD; Miller S; Flores J; Shringarpure R; Moro L; Bagin RG; Ballard ED; Totoritis MC
J Travel Med; 2014; 21(6):369-76. PubMed ID: 25345982
[TBL] [Abstract][Full Text] [Related]
2. Rifamycin SV-MMX® for treatment of travellers' diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria.
Steffen R; Jiang ZD; Gracias Garcia ML; Araujo P; Stiess M; Nacak T; Greinwald R; DuPont HL
J Travel Med; 2018 Jan; 25(1):. PubMed ID: 30462260
[TBL] [Abstract][Full Text] [Related]
3. Rifaximin treatment of pathogen-negative travelers' diarrhea.
DuPont HL; Haake R; Taylor DN; Ericsson CD; Jiang ZD; Okhuysen PC; Steffen R
J Travel Med; 2007; 14(1):16-9. PubMed ID: 17241249
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea.
Taylor DN; Bourgeois AL; Ericsson CD; Steffen R; Jiang ZD; Halpern J; Haake R; Dupont HL
Am J Trop Med Hyg; 2006 Jun; 74(6):1060-6. PubMed ID: 16760520
[TBL] [Abstract][Full Text] [Related]
5. Rifamycin SV MMX for the treatment of traveler's diarrhea.
Lin SW; Lin CJ; Yang JC
Expert Opin Pharmacother; 2017 Aug; 18(12):1269-1277. PubMed ID: 28697313
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea.
DuPont HL; Jiang ZD; Okhuysen PC; Ericsson CD; de la Cabada FJ; Ke S; DuPont MW; Martinez-Sandoval F
Ann Intern Med; 2005 May; 142(10):805-12. PubMed ID: 15897530
[TBL] [Abstract][Full Text] [Related]
7. Rifamycin SV MMX
Hoy SM
Clin Drug Investig; 2019 Jul; 39(7):691-697. PubMed ID: 31172447
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, pilot study of rifaximin 550 mg versus placebo in the prevention of travelers' diarrhea in Mexico during the dry season.
Flores J; Dupont HL; Jiang ZD; Okhuysen PC; Melendez-Romero JH; Gonzalez-Estrada A; Carrillo I; Paredes M
J Travel Med; 2011; 18(5):333-6. PubMed ID: 21896097
[TBL] [Abstract][Full Text] [Related]
9. Doxycycline prophylaxis of travelers' diarrhea in Honduras, an area where resistance to doxycycline is common among enterotoxigenic Escherichia coli.
Sack RB; Santosham M; Froehlich JL; Medina C; Orskov F; Orskov I
Am J Trop Med Hyg; 1984 May; 33(3):460-6. PubMed ID: 6375407
[TBL] [Abstract][Full Text] [Related]
10. Enterotoxigenic Escherichia coli and diffusely adherent E. coli as likely causes of a proportion of pathogen-negative travelers' diarrhea--a PCR-based study.
Meraz IM; Jiang ZD; Ericsson CD; Bourgeois AL; Steffen R; Taylor DN; Hernandez N; DuPont HL
J Travel Med; 2008; 15(6):412-8. PubMed ID: 19090795
[TBL] [Abstract][Full Text] [Related]
11. Prevention of travelers' diarrhea with rifaximin in US travelers to Mexico.
Martinez-Sandoval F; Ericsson CD; Jiang ZD; Okhuysen PC; Romero JH; Hernandez N; Forbes WP; Shaw A; Bortey E; DuPont HL
J Travel Med; 2010; 17(2):111-7. PubMed ID: 20412178
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic doxycycline for travelers' diarrhea: results of a prospective double-blind study of Peace Corps volunteers in Morocco.
Sack RB; Froehlich JL; Zulich AW; Hidi DS; Kapikian AZ; Orskov F; Orskov I; Greenberg HB
Gastroenterology; 1979 Jun; 76(6):1368-73. PubMed ID: 374178
[TBL] [Abstract][Full Text] [Related]
13. Enteroaggregative Escherichia coli diarrhea in travelers: response to rifaximin therapy.
Infante RM; Ericsson CD; Jiang ZD; Ke S; Steffen R; Riopel L; Sack DA; DuPont HL
Clin Gastroenterol Hepatol; 2004 Feb; 2(2):135-8. PubMed ID: 15017618
[TBL] [Abstract][Full Text] [Related]
14. Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone.
Ericsson CD; DuPont HL; Okhuysen PC; Jiang ZD; DuPont MW
J Travel Med; 2007; 14(5):312-9. PubMed ID: 17883462
[TBL] [Abstract][Full Text] [Related]
15. Therapy of travelers' diarrhea with rifaximin on various continents.
Steffen R; Sack DA; Riopel L; Jiang ZD; Stürchler M; Ericsson CD; Lowe B; Waiyaki P; White M; DuPont HL
Am J Gastroenterol; 2003 May; 98(5):1073-8. PubMed ID: 12809830
[TBL] [Abstract][Full Text] [Related]
16. Enteroaggregative Escherichia coli as a cause of traveler's diarrhea: clinical response to ciprofloxacin.
Glandt M; Adachi JA; Mathewson JJ; Jiang ZD; DiCesare D; Ashley D; Ericsson CD; DuPont HL
Clin Infect Dis; 1999 Aug; 29(2):335-8. PubMed ID: 10476738
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of rifaximin in prevention of travelers' diarrhea: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Hu Y; Ren J; Zhan M; Li W; Dai H
J Travel Med; 2012 Dec; 19(6):352-6. PubMed ID: 23379704
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a travelers' diarrhea vaccine system in travelers to India.
Steffen R; Cramer JP; Burchard G; Jelinek T; Schwarz U; Ramdas P; Chatterjee S; Jiang ZD; DuPont HL; Dewasthaly S; Westritschnig K; Behrens RH
J Travel Med; 2013; 20(6):374-9. PubMed ID: 24165382
[TBL] [Abstract][Full Text] [Related]
19. Oral aztreonam, a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to Mexico.
DuPont HL; Ericsson CD; Mathewson JJ; de la Cabada FJ; Conrad DA
JAMA; 1992 Apr; 267(14):1932-5. PubMed ID: 1548825
[TBL] [Abstract][Full Text] [Related]
20. Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone.
Dupont HL; Jiang ZD; Belkind-Gerson J; Okhuysen PC; Ericsson CD; Ke S; Huang DB; Dupont MW; Adachi JA; De La Cabada FJ; Taylor DN; Jaini S; Martinez Sandoval F
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):451-6. PubMed ID: 17382603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
